Biotech Values

[BTH]

I understand the JPM conference is the first big event in healthcare for the New Year, but does anything truly relevant ever come out of this event other than the typical cookie-cutter boilerplate crap that was repeated throughout the last quarter of the prior year? Or would you classify this conference as when the CEOs of the presenting companies develop their boilerplate cookie-cutter statements they will repeat, verbatim, at every conference after the JPM show throughout the entire year.